Jennifer Petter

Jennifer Petter

Company: Arrakis Therapeutics

Job title: Founder & Chief Scientific Innovation Officer

Seminars:

Panel Discussion: Discussing Investment in RNA-Targeting Therapeutics to Accelerate Advancement of Small Molecule Therapies for Patients in Need 2:00 pm

What motivation do venture capitalists need to invest in RNA targeting small molecule therapeutics? What do venture capitalists view as critical points of investment both in preclinical and early clinical development? What do investors look for in investable ideas and approaches within the RNA-targeting field?Read more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.